GRAY, Tenn.–(BUSINESS WIRE)–PPA Research Group, a leading provider of healthy and diseased human hematologic tissue and cells for global life sciences expands its business operations with a new location. As of November 1st, 2018, PPA Research will open its new donor collection facility in Berkeley, California. “We are very proud to have this new facility come on line. This is a tremendous opportunity to better serve our customers with new product offerings such as fresh bone marrow, fresh whole blood, and fresh leukopacks in multiple locations. With cutting-edge research developments in gene editing and immunotherapy it is important for us to provide immediate access to the highest quality hematologic products, with expert level customer service and technical support. That is our focus,” said Kevin King, CEO and founder.
The leukapheresis products market is expected to reach USD 27.7 million by 2023 from an estimated USD 19.4 million in 2018, at a CAGR of 7.4%.The leukopaks market is expected to reach USD 445.6 million by 2023, at a CAGR of 46.4%. Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes. The increasing incidence and prevalence of leukemia and growing demand for leukopaks for research applications are some of the factors driving the growth of these markets. However, the high cost of therapeutic leukapheresis and leukopaks and stringent donor recruitment criteria are restraining the growth of this market to a certain extent.
GRAY, Tenn.--(BUSINESS WIRE)--PPA Research Group, a leading provider of diseased human hematologic tissue and cells for global life sciences, expands its business from the wholesale product market to retail markets worldwide. PPA Research Group is now offering customers a one stop solution for both healthy and diseased hematologic products. A newly redesigned website was established to help researchers find their product(s) of interest quickly and streamline the purchasing process.